A federal judge released a decision on Friday evening halting the U.S. Food and Drug Administration’s (FDA) 2000 approval of mifepristone, the first drug used in a two-drug abortion regimen.
U.S. District Judge Matthew Kacsmaryk issued a 67-page opinion stating that the FDA unlawfully approved mifepristone. The Trump-appointed judge put his decision on hold for seven days to allow the “federal government time to seek emergency relief from the United States Court of Appeals for the Fifth Circuit.”
“Chemical abortion is only the status quo insofar as Defendants’ unlawful actions and their delay in responding to Plaintiffs’ petitions have made it so. The fact that injunctive relief could upset this ‘status quo’ is therefore an insufficient basis to deny injunctive relief,” Kacsmaryk wrote.
The Alliance Defending Freedom (ADF) filed a lawsuit in November of…
